Most Read Articles
Roshini Claire Anthony, 4 days ago

Children who are fully vaccinated against the flu, ie, receive the recommended number of influenza vaccine doses, have a lower risk of acquiring influenza compared with those who are partially vaccinated, a US study found.

06 Jul 2020
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 5 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.

More overweight, obese women with PCOS remain sedentary despite recommendations

21 Jun 2020

Sedentary behaviour remains extremely prevalent among overweight or obese women with polycystic ovary syndrome (PCOS), with a recent study reporting that only one in two women meets physical activity (PA) levels recommended for weight loss.

Researchers used data from the Australian Longitudinal Study on Women's Health. They included 7,847 women in the analysis of PA level (n=796 PCOS; n=7,051 non-PCOS) and 3,525 in the analysis of sitting time (ST; n=377 PCOS; n=3,148 non-PCOS).

In the entire cohort, 71.0 percent and 56.7 percent of women achieved PA levels recommended for weight maintenance and weight loss, respectively. Women with vs without self-reported PCOS had lower PA levels (median, 899 vs 999 MET-min/week; p=0.003) and higher ST (mean daily total, 10.3 vs 9.5 hours; p=0.006).

In each body mass index (BMI) category, the number of women who met the PA guidelines was similar between the PCOS and non-PCOS group, although the overall number became smaller as BMI category increased.

Specifically, fewer overweight or obese women with vs without PCOS aligned with PA recommendations for weight maintenance (58.7 percent vs 65.7 percent; p=0.003) or weight loss (45.1 percent vs 50.3 percent; p=0.032). Two‐thirds of women with and without self‐reported PCOS had prolonged ST (≥8 h/d), and this number remained the same after stratification by BMI.

In light of the findings, the researchers underscored a need for interventions to motivate overweight or obese women with PCOS to engage in sufficient PA and make sustainable healthy lifestyle choices.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

Children who are fully vaccinated against the flu, ie, receive the recommended number of influenza vaccine doses, have a lower risk of acquiring influenza compared with those who are partially vaccinated, a US study found.

06 Jul 2020
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, 5 days ago

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.